TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Inc. Logo GlobeNewswire Inc. • •By Jordyn Tarazi
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aligos Therapeutics granted non-qualified stock options to purchase 14,100 shares for newly hired employees under their 2024 Inducement Plan, with shares vesting over a four-year period.

Insights
EPD   positive

Has increased distributions for 27 consecutive years, operates with stable cash flow from long-term fee-based contracts, and is completing a major expansion phase


ALGS   neutral

The announcement is a routine corporate action of granting stock options to new employees, indicating standard hiring and compensation practices without significant positive or negative implications